Skip to main content
Publications
Tormos A , Thomsen RW, Tave AK, Madsen M, Beachler DC, Martinez D , Garcia Esteban R , Plana E , Farsani SF, Perez-Gutthann S , Pladevall-Vila M , Rebordosa C . Post-authorisation safety study (PASS) assessing the risk of liver, renal, genitourinary, and diabetic ketoacidosis outcomes among users of empagliflozin versus DPP-4 inhibitors in patients with type 2 diabetes mellitus (T2D) . Poster presented at the 39th ICPE Annual Conference; August 27, 2023. Halifax, Canada. [abstract] Pharmacoepidemiol Drug Saf. 2023 Oct 12; 32(S1):585. doi: 10.1002/pds.5687
Gini R, Paoletti O, Pajouheshnia R , Souverein PC, Thurin NH, Ehrenstein V, Barreiro-De Acosta M, Sturkenboom M, Gutierrez L , Perez-Gutthann S . Study scripts supporting multiple common data models . Poster presented at the 2022 ICPE Conference; August 28, 2022. Copenhagen, Denmark. [abstract] Pharmacoepidemiol Drug Saf. 2022 Sep 23; 31(S2):550. doi: 10.1002/pds.5518Pharmacoepidemiol Drug Saf.2022;31(Suppl. 2):3–628.wileyonlinelibrary.com/journal/pds© 2022 John Wiley & Sons Ltd.3
Pajouheshnia R , Gini R, Hyde E, Swertz MA, Sturkenboom M, Margulis AV , Franzoni C , Arana A , Ehrenstein V, Gembert K, Jansen E, Herings RMC, Thurin NH, Locatelli I, Jazbar J, Zerovnik S, Kos M, Smit S, Lind S, Metspalu A, Zaccagnino S, Busto MP, Middelkoop B, Barreiro-De Acosta M, Saez FS, Rodriguez-Bernal C, Sanfelix-Gimeno G, Poblador-Plou B, Carmona-Pirez J, Gimeno-Miguel A, Gil M, Schafer W, Haug U, Simou S, Hedenmalm K, Cochino A, Alcini P, Kurz X, Gutierrez L , Perez-Gutthann S . MINERVA: Metadata for data dIscoverability aNd study rEplicability in obseRVAtional studies . Poster presented at the 2022 ICPE Conference; August 28, 2022. Copenhagen, Denmark. [abstract] Pharmacoepidemiol Drug Saf. 2022 Sep 23; 31(S2):564. doi: 10:1002/pds.5518
Rebordosa C , Rubino A, Witzleb AJ, Olesen M, Plana E , Aguado J , Saigi N , Daoud SZ, Lei A, Perez-Gutthann S , Schink T, Kristiansen NS, Pottegard A, Rivero-Ferrer E . Characteristics of new users of aclidinium, aclidinium/formoterol, and other COPD medications in three European countries . Poster presented at the 2020 Virtual ERS International Congress; October 2020. [abstract] Eur Respir J. 2020 Oct 28; 56(Suppl 64):2071. doi: 10.1183/13993003.congress-2020.2072
Phiri K, Hallas J, Linder M, Margulia A , Suehs B, Arana A , Bahmanyar S, Enger C, Horter L, Odsbu I, Olesen M, Perez-Gutthann S , Sahlertz Kristiansen N, Appenteng K, de Vogel S, Seeger J. A study of cancer occurrence in users of mirabegron and antimuscarinic treatments for overactive bladder . Poster presented at the American Urological Association 2020 Conference (Conference cancelled); May 2020. Washington, DC. [abstract] J Urol. 2020 Apr; 203(Supplement 4):e910-1. doi: 10.1097/JU.0000000000000931.010
Gutierrez L , Bezemer ID, Dress J, Ehrenstein V, Forstner M, Franzoni C , Lassalle R, Linder M, Droz-Perroteau C, Odsbu I, Overbeek JA, Perez-Gutthann S , Pisa FE, Rascher K, Rasouliyan L, Reinold J, Rothman KJ , Saigi-Morgui N , Schaller M, Smits E, Timmer A, Toft G, von Gersdorff G, Fortuny J . Challenges in conducting a multinational European study of severe hypersensitivity reactions among recipients of intravenous iron . Poster presented at the 35th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 27, 2019. Philadelphia, PA. [abstract] Pharmacoepidemiol Drug Saf. 2019 Aug 20; 28(S2):640. doi: 10.1002/pds.4864
Plana E , Rivero-Ferrer E , Aguado J , Saigi-Morgui N , Nuevo J, Daoud SZ, Lei A, Perez-Gutthann S , Rebordosa C . Hospitalization for heart failure among patients using aclidinium bromide and other COPD medications: a post-authorisation safety study in the CPRD . Poster presented at the 35th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 28, 2019. Philadelphia, PA. [abstract] Pharmacoepidemiol Drug Saf. 2019 Aug 20; 28(S2):1153. doi: 10.1002/pds.4864
Saigi N , Rebordosa C , Bui C , Aguado J , Plana E , Nuevo J, Daoud SZ, Lei A, Perez-Gutthann S , Rivero-Ferrer E . A validation exercise: identifying hospitalizations for heart failure among patients with COPD in the CPRD . Poster presented at the 35th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 26, 2019. Philadelphia, PA. [abstract] Pharmacoepidemiol Drug Saf. 2019 Aug 20; 28(S2):334. doi: 10.1002/pds.4864
Forns J , Pottegard A, Reinders T, Poblador-Plou B, Morros R, Brandt L, Cainzos-Achirica M, Hellfritzsch M, Schink T, Prados-Torres A, Giner-Soriano M, Hallas J, Cortes J, Hagg D, Jacquot E, Deltour N, Perez-Gutthann S , Pladevall M , Reutfors J. Antidepressant use in Denmark, Germany, Spain, and Sweden from 2009 to 2014: incidence and comorbidities of antidepressant initiators . Poster presented at the 35th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 27, 2019. Philadelphia, PA. [abstract] Pharmacoepidemiol Drug Saf. 2019 Aug 20; 28(S2):560. doi: 10.1002/pds.4864
Tormos A , Rebordosa C , Thomas S, Plana E , Rasouliyan L, Pladevall-Vila M , Fazeli-Farsani S, Deruaz-Luyet A, Brodovicz KG, Perez-Gutthann S . Time between laboratory tests and acute liver and kidney injury diagnosis codes in CPRD: are we doing it right? Poster presented at the 34th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 26, 2018. Prague, Czech Republic. [abstract] Pharmacoepidemiol Drug Saf. 2018 Aug; 27(S2):452. doi: 10.1002/pds.4629
Pladevall M , Hallas J, Schink T, Morros R, Poblador-Plou B, Forns J , Hellfritzsch M, Reinders T, Giner-Soriano M, Prados-Torres A, Cainzos-Achirica M, Pottegard A, Kollhorst B, Cortes J, Aguado J , Perlemuter G, Castellsague J, Jacquot E, Deltour N, Perez-Gutthann S . Agomelatine and risk of hospitalization for acute liver injury: nested case-control study in Spain, Germany, and Denmark . Poster presented at the 33rd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 29, 2017. Montreal, Canada. [abstract] Pharmacoepidemiol Drug Saf. 2017 Aug; 26(Suppl 2):389. doi: 10.1002/pds
Castellsague J, Calingaert B , Poblador-Plou B, Giner-Soriano M, Linder M, Scholle O, Arana A , Bui C , Laguna C, Prados-Torres A, Roso-Llorach A, Perez-Gutthann S . Impact of risk minimization measures on the use of cilostazol in Europe . Poster presented at the 33rd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 29, 2017. Montreal, Canada. [abstract] Pharmacoepidemiol Drug Saf. 2017 Aug; 26(Suppl 2):428. doi: 10.1002/pds
Cainzos-Achirica M, Varas-Lorenzo C, Pottegard A, Asmar J, Plana E , Rasmussen L, Bizouard G, Forns J , Hellfritzsch M, Zint K, Perez-Gutthann S , Pladevall-Vila M . Evaluation of potential off-label prescribing of dabigatran etexilate in France, Denmark, and the United Kingdom and associated methodological challenges . Poster presented at the 33rd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 30, 2017. Montreal, Canada. [abstract] Pharmacoepidemiol Drug Saf. 2017 Aug; 26(Suppl 2):566. doi: 10.1002/pds
Arana A , Varas-Lorenzo C, McQuay LJ, Ziemiecki R , Bui CL , Gilsenan AW , Rothman KJ , Atsma WJ, Appenteng K, Franks B, de Vogel S, D'Silva M, Margulis AV , Perez Gutthann S . Do individual antimuscarinic drugs to treat overactive bladder have different cardiovascular risks? A UK CPRD cohort study . Poster presented at the 32nd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 28, 2016. Dublin, Ireland. [abstract] Pharmacoepidemiol Drug Saf. 2016 Aug; 25(Suppl 3):534-5.
Castellsague J, Calingaert B , Rothman KJ , Gutierrez L , van Herk-Sukel MPP, Kuiper JG, Pottegard A, Hallas J, Berglind IA, Sundstrom A, Dedman D, Gallagher A, Kaye JA, Pardo C, Perez-Gutthann S . Probabilistic bias analysis for unmeasured confounders in a study of users of topical tacrolimus, pimecrolimus, and corticosteroids (JOELLE) study . Poster presented at the 32nd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 26, 2016. Dublin, Ireland. [abstract] Pharmacoepidemiol Drug Saf. 2016 Aug; 25(Suppl 3):142-3.
Castellsague J, Kuiper JJG, Pottegard A, Berglind IA, Dedman D, Gutierrez L , Calingaert B , van Herk-Sukel MPP, Hallas J, Sundstrom A, Gallagher A, Kaye JA, Pardo C, Rothman KJ , Perez-Gutthann S . Risk of lymphoma in users of topical tacrolimus, pimecrolimus and corticosteroids (JOELLE study) . Poster presented at the 32nd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 28, 2016. Dublin, Ireland. [abstract] Pharmacoepidemiol Drug Saf. 2016 Aug; 25(Suppl 3):494-5.
Castellsague J, van Herk-Sukel MPP, Hallas J, Sundstrom A, Gallagher A, Gutierrez L , Calingaert B , Kuiper JG, Pottegard A, Berglind IA, Dedman D, Kaye JA, Pardo C, Rothman KJ , Perez-Gutthann S . Risk of skin cancer in users of topical tacrolimus, pimecrolimus, and corticosteroids. JOint European Longitudinal Lymphoma and skin cancer Evaluation (JOELLE) study . Poster presented at the 32nd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 28, 2016. Dublin, Ireland. [abstract] Pharmacoepidemiol Drug Saf. 2016 Aug; 25(Suppl 3):527.
Castellsague J, Calingaert B , Poblador-Plou B, Giner-Soriano M, Linder M, Scholle O, Varas-Lorenzo C, Arana A , Bui C , Prados-Torres A, Gonzalez-Rubio F, Roso-Llorach A, Citarella A, Garbe E, Blenk T, Perez-Gutthann S . Characterization of new users of cilostazol in the United Kingdom, Spain, Sweden, and Germany . Poster presented at the 32nd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 26, 2016. Dublin, Ireland. [abstract] Pharmacoepidemiol Drug Saf. 2016 Aug; 25(Suppl 3):203-4.
Margulis A , Houben E, Olesen M, Hallas J, Overbeek J, Pottegard A, Ye W, Villegas D, Perez-Gutthann S , Arana A . Drug utilization study: evaluation of the use of nepafenac in the Netherlands and Denmark . Poster presented at the 32nd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 26, 2016. Dublin, Ireland. [abstract] Pharmacoepidemiol Drug Saf. 2016 Aug; 25(Suppl 3):225.
Margulis AV , Linder M, Arana A , Pottegard A, Anveden-Berglind I, Bui CL , Kristiansen NS, Bahmanya S, McQuay LJ, Atsma WJ, Appenteng K, Franks B, de Vogel S, D'Silva M, Perez-Gutthann S , Hallas J. Patterns of use of antimuscarinic drugs to treat overactive bladder in Denmark, Sweden, and the United Kingdom . Poster presented at the 32nd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 28, 2016. Dublin, Ireland. [abstract] Pharmacoepidemiol Drug Saf. 2016 Aug; 25(Suppl 3):653.
Hallas J, Margulis AV , Pottegard A, Kristiansen N, Bui CL , Krueger W, Atsma WJ, Appenteng K, Franks B, de Vogel S, D 'Silva M, Perez-Gutthann S , Arana A . Incidence of cardiovascular events in new users of overactive bladder medications in Denmark . Poster presented at the 32nd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 28, 2016. Dublin, Ireland. [abstract] Pharmacoepidemiol Drug Saf. 2016 Aug; 25(Suppl 3):491.
Hallas J, Margulis AV , Pottegard A, Kaye JA, Kristiansen N, Bui CL , Atsma WJ, Appenteng K, Franks B, de Vogel S, D'Silva M, Perez-Gutthann S , Arana A . Elevated bladder and prostate cancer rates following initiation of OAB medication: findings from the Danish Registries . Poster presented at the 32nd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 28, 2016. Dublin, Ireland. [abstract] Pharmacoepidemiol Drug Saf. 2016 Aug; 25(Suppl 3):533.
Fortuny J , Kaye JA, Bui CL , Gilsenan AW , Bartsch J , Plana E , McQuay LJ, Calingaert B , Atsma WJ, Appenteng K, Franks B, de Vogel S, D'Silva M, Perez Gutthan S , Arana A , Margulis AV . Evaluation of free-text comments to validate common cancer diagnoses in the UK CPRD . Poster presented at the 32nd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 26, 2016. Dublin, Ireland. [abstract] Pharmacoepidemiol Drug Saf. 2016 Aug; 25(Suppl 3):58.
Linder M, Margulis AV , Anveden-Berglind I, Bahmanyar S, Bui CL , Atsma WJ, Appenteng K, Franks B, de Vogel S, D'Silva M, Perez-Gutthann S , Arana A . Cardiovascular risk in users of antimuscarinic drugs for overactive bladder: a cohort study in the Swedish National Registers . Poster presented at the 32nd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 28, 2016. Dublin, Ireland. [abstract] Pharmacoepidemiol Drug Saf. 2016 Aug; 25(Suppl 3):491-2.
Linder M, Margulis AV , Anveden-Berglind I, Bahmanyar S, Bui CL , Atsma WJ, Appenteng K, Franks B, de Vogel S, D'Silva M, Perez-Gutthann S , Arana A . Cancer risk in users of antimuscarinic drugs for overactive bladder: a cohort study in the Swedish National Registers . Poster presented at the 32nd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 28, 2016. Dublin, Ireland. [abstract] Pharmacoepidemiol Drug Saf. 2016 Aug; 25(Suppl 3):533-4.
Kuiper JG, van Herk-Sukel MPP, Castellsague J, Potttegard A, Berglind IA, Dedman D, Calingaert B , Hallas J, Sundstrom A, Gallagher AM, Kaye JA, Pardo C, Rothman KJ , Perez-Gutthann S . Utilization of tacrolimus and pimecrolimus in Europe: results from the JOint European Longitudinal Lymphoma and skin cancer Evaluation (JOELLE) study . Poster presented at the 32nd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 28, 2016. Dublin, Ireland. [abstract] Pharmacoepidemiol Drug Saf. 2016 Aug; 25(Suppl 3):630-1.
Garratt C, Weatherall M, Pohjanjousi P, Aantao R, Conti G, Lewis M, Moore N, Perez-Gutthann S . A multinational, drug utilisation study to investigate the use of dexmedetomidine (DEXDOR®) in clinical practice in the EU . Poster presented at the 2015 ESICM's 28th Annual Congress; October 3, 2015. Berlin, Germany. [abstract] Intensive Care Med Exp. 2015 Oct 1; 3(Suppl 1):A322. Previously presented at the 31st ICPE International Conference on Pharmacoepidemiology and Therapeutic Risk Management. doi: 10.1186/2197-425X-3-S1-A322
Masclee GMC, Valkoff VE, Straatman H, Herings R, Garbe E, Schink T, Kollhorst B, Arfe A, Lucchi S, Villa M, Castellsague J, Perez-Gutthann S , Varas-Lorenzo C, Schade R, Schuemie M, Vergouwe Y, Steyerberg E, Sturkenboom M, Romio S. Individualized NSAID prescribing based on gastrointestinal and cardiovascular risks: a decision model in the SOS project . Poster presented at the 31st ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2015. Boston, MA. [abstract] Pharmacoepidemiol Drug Saf. 2015 Sep; 24(S1):36-7. doi: 10.1002/pds.3838
Kaye JA, Castellsague J, Bui C , Calingaert B , McQuay LJ, Riera N , Saltus C , Quinlan S, Holick CN, Wahl PM, Suzart K, Rothman KJ , Wallander MA, Perez-Gutthann S . Risk of acute liver injury in a cohort of oral antimicrobial users . Poster presented at the 28th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2012. Barcelona, Spain. [abstract] Pharmacoepidemiol Drug Saf. 2012 Aug 27; 21(Supp 3):92. doi: 10.1002/phar.1367
Afonso A, Prieto-Alhambra D, Escudero Garcia A, Estany Gestal A, Martin-Merino E, Riera Guardia N , Lopez-Leon S, Perez-Gutthann S , Hernández-Díaz S. FarmacoEpiEnRed, a network for pharmacoepidemiology in Spain . Poster presented at the 28th International Conference on Pharmacoepidemiology; August 27, 2012. Barcelona, Spain. [abstract] Pharmacoepidemiol Drug Saf. 2012 Aug 27; 21(Suppl 3):193. doi: 10.1002/pds.3324
Castellsague J, Pisa F, Rosolen V, Riera-Guardia N , Giangreco M, Clagnan E, Tosolini F, Zanier L, Barbone F, Perez-Gutthann S . Use of nimesulide, other nsaids and the risk of upper gastrointestinal complications in Friuli Venezia Giulia, Italy. Analysis of cases with codes with high positive predictive value . Poster presented at the 27th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2011. Chicago, IL. [abstract] Pharmacoepidemiol Drug Saf. 2011 Aug; 20(S1):S178.